Lactobacillus for preventing recurrent urinary tract infections in women: Meta-analysis

Canadian Journal of Urology

Volumn 20, Issue 1, 2013, Pages 6607-6614

  Grin, Peter M ^a,b   Kowalewska, Paulina M ^a   Alhazzani, Waleed ^a   Fox Robichaud, Alison E ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cystitis; Lactobacillus; Meta analysis; Probiotics; Systematic review; Urinary tract infection

Indexed keywords

BIOLOGICAL THERAPY; FEMALE; HUMAN; LACTOBACILLUS; META ANALYSIS; MICROBIOLOGY; RECURRENT DISEASE; REVIEW; SUPPOSITORY; URINARY TRACT INFECTION; VAGINA;

BIOLOGICAL THERAPY; FEMALE; HUMANS; LACTOBACILLUS; RECURRENCE; SUPPOSITORIES; URINARY TRACT INFECTIONS; VAGINA;

EID: 84880708778     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Mircescu G. Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections. Roum Arch Microbiol Immunol 2003;62(3-4):137-154.
2. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000;10(8):509-515.
3. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990;80(3):331-333.
4. Ikaheimo R, Siitonen A, Heiskanen T et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996;22(1):91-99.
5. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52(5):e103-120.
6. Kodner CM,Thomas Gupton EK. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician 2010;82(6):638-643.
7. Albert X, Huertas I, Pereiro, II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in nonpregnant women. Cochrane Database Syst Rev 2004(3):CD001209.
8. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated communityacquired urinary tract infections. Ann Intern Med 2001;135(1):41-50.
9. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281(8):736-738.
10. Joint FAO/WHO Working Group. Guidelines for the Evaluation of Probiotics in Food. Available from: http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/index.html. Accessed July 9th, 2012.
11. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus byproducts inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009;60(Suppl 6):13-18.
12. Abad CL, Safdar N. The role of Lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review. J Chemother 2009;21(3):243-252.
13. Stapleton AE, Au-Yeung M, Hooton TM et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011;52(10):1212-1217.
14. Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560.
16. Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol 2007;2007:35387.
17. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322(7302):1571.
18. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994;12(4):239-243.
19. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992;14(1):11-16.
20. Jones ML, Martoni CJ, Di Pietro E, Simon RR, Prakash S. Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: A randomized control trial. Regul Toxicol Pharmacol 2012;63(2):313-320.
21. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30(1):49-52.
22. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecology and Therapy 1995;23:32-45.
23. Coudeyras S, Jugie G, Vermerie M, Forestier C. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect Dis Obstet Gynecol 2008;2008:549640.
24. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 2003;5(11):767-769.
25. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001;32(1):37-41.
26. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000;182(4):1177-1182.
27. Smith HS, Hughes JP, Hooton TM et al. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis 1997;25(1):63-68.
28. Hooton TM, Scholes D, Hughes JP et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996;335(7):468-474.
29. Fihn SD, Boyko EJ, Normand EH et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol 1996;144(5):512-520.
30. Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998;178(2):446-450.
31. Osset J, Bartolome RM, Garcia E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001;183(3):485-491.
32. Reid G, Dols J, Miller W. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care 2009;12(6):583-587.
33. Borchert D, Sheridan L, Papatsoris A et al. Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urol 2008;24(2):139-144.
34. Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 2006;66(9):1253-1261.